PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19

MR Khezri - Human Cell, 2021 - Springer
To the editor Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses a major challenge to the world's healthcare …
被引用次数：41 相关文章

[引用][C] PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19

MR Khezri - Human cell, 2021 - pubmed.ncbi.nlm.nih.gov
PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19 PI3K/AKT
signaling pathway: a possible target for adjuvant therapy in COVID-19 Hum Cell. 2021 Mar;34(2):700-701 …

PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19

MR Khezri - Human Cell, 2021 - ncbi.nlm.nih.gov
To the editor Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses a major challenge to the world's healthcare …
[PDF] researchgate.net

[PDF][PDF] PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID‑19

MR Khezri - Human Cell, 2021 - researchgate.net
To the editor Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses a major challenge to the world's healthcare …

PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19.

MR Khezri - Human Cell, 2021 - europepmc.org
To the editor Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), poses a major challenge to the world's healthcare …

[引用][C] PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19

MR Khezri - Human Cell, 2021 - cir.nii.ac.jp
PI3K/AKT signaling pathway: a possible target for adjuvant therapy in COVID-19 | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …